Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

As Financial Turmoil Engulfs West, Germany’s Bayer Looks East To Form R&D Center In Rising China

This article was originally published in PharmAsia News

Executive Summary

BEIJING - German pharmaceutical powerhouse Bayer Schering is engineering an alliance with Chinese scientists to create a global research and development center in Beijing, according to senior Bayer executives

You may also be interested in...



Bayer’s Alok Kanti On Price Cuts And Lower-tier Markets In China: An Interview With PharmAsia News

In his first public interview since assuming leadership for Bayer Healthcare China in July, Alok Kanti discusses Bayer’s strategy in China.

Bayer’s Alok Kanti On Price Cuts And Lower-tier Markets In China: An Interview With PharmAsia News

In his first public interview since assuming leadership for Bayer Healthcare China in July, Alok Kanti discusses Bayer’s strategy in China.

China Will Seize Ranking As Globe's Top Innovative Center From U.S. By 2020: AstraZeneca Survey

BEIJING - A survey commissioned by British-headquartered AstraZeneca that polled public perceptions across three continents - Europe, North America and Asia -predicts that China will dethrone the United States to become the globe's most innovative center by 2020

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC070815

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel